<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Senores Pharmaceuticals Ltd. — News on 6ix</title>
    <link>https://6ix.com/company/senores-pharmaceuticals-l</link>
    <description>Latest news and press releases for Senores Pharmaceuticals Ltd. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Sat, 04 Apr 2026 00:01:54 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/senores-pharmaceuticals-l" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo68364ec778dffbe2df154a93.webp</url>
      <title>Senores Pharmaceuticals Ltd.</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l</link>
    </image>
    <item>
      <title>Press Release Apr 03 2026</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-apr-03-2026-5</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-apr-03-2026-5</guid>
      <pubDate>Sat, 04 Apr 2026 00:01:54 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding media release</description>
    </item>
    <item>
      <title>Press Release Jan 20 2026</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-jan-20-2026-16</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-jan-20-2026-16</guid>
      <pubDate>Tue, 20 Jan 2026 19:16:13 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding the media release in relation to the Unaudited Standalone and Consolidated financial results of the Company for the quarter and nine months ended December 31, 2025.</description>
    </item>
    <item>
      <title>Press Release Dec 11 2025</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-dec-11-2025-10</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-dec-11-2025-10</guid>
      <pubDate>Fri, 12 Dec 2025 02:31:15 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 11, 2025, titled &quot;Senores Pharmaceuticals, Inc.  announces the approval and launch of Deferiprone Tablets USP, 500 mg &amp; 1000 mg which will be marketed by Dr. Reddy s Laboratories Inc. in the US market&quot;.</description>
    </item>
    <item>
      <title>Press Release Dec 05 2025</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-dec-05-2025-11</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-dec-05-2025-11</guid>
      <pubDate>Fri, 05 Dec 2025 20:16:08 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 05, 2025, titled &quot;Senores Pharmaceuticals receives Philippine FDA approval for 10 products&quot;.</description>
    </item>
    <item>
      <title>Press Release Nov 06 2025</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-nov-06-2025-33</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-nov-06-2025-33</guid>
      <pubDate>Thu, 06 Nov 2025 19:11:38 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding a media release dated November 06, 2025, titled &quot;Strong Financial &amp; Operational Performance for Q2 &amp; H1 FY26&quot;.</description>
    </item>
    <item>
      <title>Press Release Aug 12 2025</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-aug-12-2025-29</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-aug-12-2025-29</guid>
      <pubDate>Tue, 12 Aug 2025 23:51:10 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 12, 2025, titled &quot;Senores Pharmaceuticals acquires ANDAs from Teva Pharmaceuticals USA, Inc.&quot;.</description>
    </item>
    <item>
      <title>Press Release Jul 23 2025</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-jul-23-2025-22</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-jul-23-2025-22</guid>
      <pubDate>Wed, 23 Jul 2025 23:25:52 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding  the media release in relation to the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2025</description>
    </item>
    <item>
      <title>Press Release May 20 2025</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-may-20-2025-21</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-may-20-2025-21</guid>
      <pubDate>Tue, 20 May 2025 19:42:36 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding Media Release-&quot;Senores Pharmaceuticals acquires ANDA for Enalapril Maleate Tablets 2.5mg, 5mg, 10mg and 20mg from Wockhardt&quot;</description>
    </item>
    <item>
      <title>Press Release May 15 2025</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-may-15-2025-25</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-may-15-2025-25</guid>
      <pubDate>Fri, 16 May 2025 01:01:03 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding a Media release dated May 15, 2025 in relation to the Audited Standalone and Consolidated financial results of the Company for the quarter and financial year ended March 31, 2025.</description>
    </item>
    <item>
      <title>Press Release May 09 2025</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-may-09-2025-13</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-may-09-2025-13</guid>
      <pubDate>Fri, 09 May 2025 12:57:43 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 09, 2025, titled &quot;Senores Pharmaceuticals acquires ANDA for Tramadol Tablets from APDMPharmaceuticals.</description>
    </item>
    <item>
      <title>Press Release May 05 2025</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-may-05-2025-15</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-may-05-2025-15</guid>
      <pubDate>Mon, 05 May 2025 20:52:54 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding a media release dated May 05, 2025, titled &quot;Senores Pharmaceuticals acquires ANDA for Topiramate HCl 25,50,100 and 200 mg tablets&quot;.</description>
    </item>
    <item>
      <title>Press Release Mar 04 2025</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-mar-04-2025-16</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-mar-04-2025-16</guid>
      <pubDate>Tue, 04 Mar 2025 19:14:13 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 04, 2025, titled &quot;Senores Pharmaceuticals acquires 14 ANDAs from Dr. Reddy s Laboratories&quot;.</description>
    </item>
    <item>
      <title>Press Release Feb 26 2025</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-feb-26-2025-3</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-feb-26-2025-3</guid>
      <pubDate>Wed, 26 Feb 2025 20:39:54 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 26, 2025, titled &quot;Senores Pharmaceuticals begins operations at greenfield API facility&quot;.</description>
    </item>
    <item>
      <title>Press Release Feb 20 2025</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-feb-20-2025-12</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-feb-20-2025-12</guid>
      <pubDate>Fri, 21 Feb 2025 03:13:43 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 20, 2025, titled &quot;Senores Pharmaceuticals acquires ANDA for Roflumilast 250 mcg and 500 mcg tablets&quot;.</description>
    </item>
    <item>
      <title>Press Release Jan 23 2025</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-jan-23-2025-19</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-jan-23-2025-19</guid>
      <pubDate>Thu, 23 Jan 2025 19:03:47 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 23, 2025, titled &quot;Stellar Financial &amp; Operational Performance for Q3 &amp; 9MFY25&quot;.</description>
    </item>
    <item>
      <title>Press Release Jan 09 2025</title>
      <link>https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-jan-09-2025-13</link>
      <guid isPermaLink="true">https://6ix.com/company/senores-pharmaceuticals-l/news/press-release-jan-09-2025-13</guid>
      <pubDate>Fri, 10 Jan 2025 03:04:11 GMT</pubDate>
      <description>Senores Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 09, 2025, titled &quot;Senores Pharmaceuticals receives ANDA approval for marketing MetoprololTartrate and Hydrochlorothiazide Tablet USP, 50 mg/25 mg and 100 mg/25 mg&quot;.</description>
    </item>
  </channel>
</rss>